NCBiotech News

We work hard to bring you the stories about the life science community in North Carolina. Every once in a while, we add a little news of our own. Read some of those stories below, or check out some of our perspectives on our staff blog.

bluebird bio logo
bluebird bio, a Massachusetts-based gene and cell therapy company, has opened its first wholly owned manufacturing facility in Durham amid cheers from state leaders.
Exela logo
Lenoir is a small town in the rural foothills, away from the state’s renowned technology hubs. But it's home to Exela Pharma Sciences, a fast-growing manufacturer of generic sterile injectable medications backed by venture capital, government grants and loans, investments by family and friends and personal funds of founder Phanesh Koneru. In its first decade it has grown to 320 employees, and it’s hiring more.
Pairwise logo
Pairwise, one of the Triangle area’s fast-growing agriculture and food biotech companies, has licensed some advanced CRISPR genome editing technologies from two prestigious Boston institutions to expand its crop-editing applications and bring new foods to market.
Fervent logo
Fervent Pharmaceuticals, a clinical-stage drug development company based in Greenville, has announced positive results from its Phase 2A clinical trial of FP-101, a non-hormonal, non-herbal, non-antidepressant treatment of the vasomotor symptoms that accompany menopause.
Verdesian logo
Cary-based agricultural technology company Verdesian Life Sciences' global workforce of 225 strives to advance the company’s goal “to enable a sustainable future for farmers through nutrient use efficiency.”
Aerie logo
Durham-based Aerie Pharmaceuticals, a developer of therapies for eye diseases, has received approval from the U.S. Food and Drug Administration to begin selling Rocklatan, a once-daily eye drop for reducing high intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
Ned Sharpless photo
Norman E. “Ned” Sharpless, M.D., who is currently director of the National Cancer Institute, was named acting commissioner Tuesday to replace FDA Commissioner Scott Gottlieb, M.D. Gottlieb unexpectedly announced his resignation March 5.
NCBiotech entry
North Carolina’s Research Triangle region is among the nation’s largest and fastest-growing markets in the life sciences, according to a new report by Los Angeles-based CBRE Group, the world’s largest commercial real estate services and investment firm.
IQVIA logo
To add momentum to the fast-growing field of precision medicine, Durham-based IQVIA has launched a patented new technology platform for life science customers to access big data needed for a wide range of research activities.
Personalized Medicine Research and Adoption Forum
The Personalized Medicine Coalition promotes policies that support personalized medicine and encourages physicians to integrate personalized medicine in clinical settings.
Cellectis logo
Paris-based biotechnology company Cellectis announced plans today to invest nearly $70 million and create 200 jobs in Raleigh, at what will become its first North American manufacturing facility.
iStock photo of girl eating burger
Want to know what people think of Raleigh? Or Charlotte? Where to buy your next McMeal? Then check out Numbeo. It's saying Raleigh and Charlotte are among the best metros in the world for quality of life.
Sagent Pharmaceuticals North Raleigh factory
A north Raleigh drug-manufacturing site purchased in 2014 by Denmark-based Xellia Pharmaceuticals has been sold again -- this time to Sagent Pharmaceuticals of Schaumburg, Illinois.
Precision BioSciences loto
Durham-based Precision BioSciences, a genome-editing company focused on creating better foods and medicines, wants to raise up to $100 million in an initial public offering (IPO) of stock.
Dignify Therapeutics logo
Dignify Therapeutics, a virtual drug development company in Research Triangle Park, has received a $3.6 million federal grant to help develop its lead drug candidate for a future Phase 1 clinical study.